Piper upgrades Forest Labs (FRX -0.2%) to Overweight from Neutral. Price target is $67.
Morgan Stanley cuts AbbVie (ABBV -3.3%) to Equalweight from Overweight.
Leerink downgrades Solta Medical (SLTM) to Market Perform from Outperform.
Stifel cuts Puma Biotechnology (PBYI -0.8%) to Hold from Buy.
Chardan starts Rockwell Medical (RMTI +3.2%) at Buy. Price target is $22.
JMP starts Chelsea Therapeutics (CHTP +5.5%) at Market Outperform. Price target is $8.